Form 4: Astera Labs Director Manuel Alba Sells Shares Under 10b5-1 Trading Plan

Director Manuel Alba of Astera Labs sold shares of the company's common stock on November 7th and 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Manuel Alba, a director at Astera Labs, sold shares of the company's common stock on November 7th and 8th, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
• The transactions involved multiple sales at varying prices, ranging from $94.49 to $99.74 per share.
• The sales were made from shares held directly and indirectly through Casa Alameda 2007, LLC and the Alba Trust.
• Following the reported transactions, Alba continues to hold a significant number of shares indirectly through Casa Alameda 2007, LLC and the Alba Trust, as well as shares held by a spouse.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives and directors to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information. The impact on the stock price is usually minimal unless the sales are unusually large or frequent.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates